Optalert is the only company in the world that can detect drowsiness and quantify an individual's alertness level using the patented Johns Drowsiness Scale. The company's technology assesses a user's drowsiness level in real-time by measuring eyelid blinks and assigns them a risk score between one and 10. Optalert's wearable technology is designed to prevent accidents caused by drowsiness and reduce risk in workplaces. The company is also using its expertise in Blepharometry and Artificial Intelligence to identify biomarkers for neurological conditions such as Epilepsy, ADHD, Parkinson's, Alzheimer's, TBI, concussion, and motor neuron disease. Optalert's clients include BHP Billiton, Vale, and NASA, and its research partners include Harvard Medical School, Monash University, and the University of Queensland.